Randall Evans, Ph.D.

Global VP, Medical and Scientific Innovation at BD Biosciences @ BD

About

Executive professional in precision medicine drug development, biomarker discovery and diagnostics with over 26 years of experience in building operationally effective teams in R&D pre-clinical, translational and clinical research along with drug, device, diagnostics, companion diagnostics and biomarker development leading to innovative patient and research impacting breakthroughs. My professional experience has focused on building operationally effective execution teams and on clinical and translational research leadership. Building strong global collaborations and strategic alliances in therapeutic, device, diagnostic and companion diagnostic development has also been a key endeavor throughout my career. I have successfully led teams in the design and oversight of thousands of clinical trials and research and development projects at my current company BD Biosciences and with my prior organizations Invitae/ArcherDX, AstraZeneca, Celldex, Biodesix, Merck, Genentech/Roche, Novartis and M.D. Anderson Cancer Center. I have also built Program Management, R&D, Translational Medicine, Clinical Development and Medical Affairs teams in support of scientific strategy, clinical, regulatory and commercial endeavors. I have also been involved in the development and commercial launch of 18 new therapies and 12 diagnostics.

Country

United States

City

Houston

Industry

Biotechnology

Skill

Genetic Testing, Molecular Biology, Strategic Leadership, Oncology Clinical Research, Agile Methodologies, Competitive Landscape, Data Analysis, Program Management, Drug Discovery, Regulatory Affairs, Medical Research, Regulatory Submissions, Product Development, Research and Development (R&D), Good Clinical Practice (GCP), Medical Devices, Biopharmaceuticals, Strategy, Business Development, Clinical Development

Experience

Global VP, Medical and Scientific Innovation at BD Biosciences

2021-12 - Present · 4 yrs 10 mos

• Business Unit Medical Officer • Clinical, Medical Device, Reagent Diagnostics (RUO, IVD and CDx) and Informatics Development • Leading global medical and scientific development and strategy for BD Biosciences portfolio of immunology, immune-oncology and hematology focused clinical, diagnostic, companion diagnostic, medical device, assay and reagent portfolio • Leading assay and strategic development for clinical and research multiparametric and spectral flow cytometry, single cell multiomics platforms, reagents and informatics • Overseeing clinical programs in leukemia, lymphoma, immune-oncology, cell therapy, minimum residual disease and HIV • Overseeing research applications and collateral development in immunology, cell biology, proteomics, single cell multiomics, spacial biology, etc. • Directing global teams of MDs, PhDs and other professionals in North America, LATAM, EMEA and Asia

President: Pharmaceutical, Diagnostics, Companion Diagnostics and Device Consultancy

Interphase Solutions

2021-9 - Present · 5 yrs 1 mo

• Board level Clinical, Regulatory, Financial and Programmatic advisory in Life Sciences • Expertise in Pharmaceutical, Diagnostics and Medical Device Development

Vice President, R&D Diagnostics, Companion Diagnostics and Clinical Development

ArcherDX, Inc.

2019-9 - 2021-9 · 2 yrs 1 mo

• Officer of the company for ArcherDx culminating in the successful acquisition by Invitae in October 2020: • Built and led the ArcherDX IVD/Companion Diagnostics (CDx) team in Advancing Personalized Medicine: R&D Clinical Development/Operations, Biostatistics, Computational Biology, Bioinformatics, Biorepository, Program Management, etc.

Head of R&D Oncology Diagnostics and Clinical Development

Invitae

2019-9 - 2021-9 · 2 yrs 1 mo

• Invitae acquired ArcherDx in October 2020: Building and Leading the Invitae teams in Advancing Personalized Medicine and Companion Diagnostics: R&D Clinical Development, Clinical Operations, Biostatistics, Data Science, Biorepository, Program Management and other functions.

Head of External Collaborations and NCI Lead

AstraZeneca

2017-8 - 2019-9 · 2 yrs 2 mos

• Leading external collaborative clinical and translational research efforts between AstraZeneca and external agencies

Head, Field Medical, Clinical Sciences

Celldex

2016-8 - 2017-8 · 1 yr 1 mo

Vice President, Global Translational Medicine, Clinical Development and Medical Affairs

Biodesix, Inc.

2015-6 - 2016-8 · 1 yr 3 mos

Houston, Texas Area

• Acting CMO, Officer of the company and member of Executive Leadership Team • Led an international team of Physicians, Pharmacists, Ph.Ds. and other professionals in precision medicine, medical, clinical and translational therapeutic and biomarker/diagnostic and companion diagnostics development